Obsessive-compulsive disorder Trials in Toronto, Canada
Conditions / Obsessive-compulsive disorder / Toronto, Canada
Research into Obsessive-compulsive disorder spans multiple therapeutic approaches and trial phases.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT04693351 | Efficacy and Safety Study of Adjunctive Troriluzule in Obsessive Compulsive Disorder | COMPLETED | PHASE3 |
| NCT01674361 | A Study of Bitopertin (RO4917838) in Combination With Selective Serotonin Reuptake Inhibitors (SSRIs) in Participants With Obsessive-Compulsive Disorder (OCD) | COMPLETED | PHASE2 |
| NCT03273699 | Mindfulness Meditation Utilizing an EEG Biofeedback Device for the Treatment for Obsessive Compulsive Disorder | COMPLETED | NA |
| NCT04914923 | Mindfulness-Based Interventions for OCD | ACTIVE_NOT_RECRUITING | NA |
| NCT02136953 | Physical Exercise in OCD: Treatment Efficacy, Additive Benefits to CBT, and Cognitive Correlates of Change | COMPLETED | NA |
| NCT03156335 | Trial of MR-guided Focused Ultrasound (MRgFUS) Bilateral Capsulotomy for the Treatment of Refractory Obsessive-compulsive Disorder (OCD) | COMPLETED | NA |
| NCT04708834 | Long-term Safety Study of Adjunctive Troriluzole in Subjects With Obsessive Compulsive Disorder | TERMINATED | PHASE3 |
| NCT04154085 | Narrative Therapy for Treatment-Resistant Obsessive-Compulsive Disorder | COMPLETED | NA |
| NCT01596608 | Magnetic Seizure Therapy (MST) for Treatment Resistant Depression, Schizophrenia, and Obsessive Compulsive Disorder | COMPLETED | NA |
| NCT02229903 | An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD | COMPLETED | NA |